Novartis Ag (NVS) Invested Capital (2009 - 2026)

Novartis Ag has reported Invested Capital for 18 years, with the latest figure at $9.6 billion in Q2 2026.

• Quarterly Invested Capital rose 15.32% year-over-year to $9.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $47.5 billion (up 12.12% YoY) and the FY2025 annual result came in at $37.9 billion, up 11.42% from the prior year.
• Invested Capital advanced to $9.6 billion in Q2 2026 per NVS's latest filing, from -$19.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $37.9 billion in Q4 2025 and troughed at -$19.0 million in Q1 2026.
• A 5-year average of $17.3 billion and a median of $9.6 billion in 2026 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2023 and 2024: Invested Capital tumbled 64.88% in 2023, then advanced 15.56% in 2024.
• Over 5 years, Invested Capital stood at $31.3 billion in 2022, then decreased by 5.82% to $29.4 billion in 2023, then rose by 15.56% to $34.0 billion in 2024, then increased by 11.42% to $37.9 billion in 2025, then sank by 74.71% to $9.6 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $9.6 billion, -$19.0 million, and $37.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.